Journals / Türk Pediatri Arşivi / 2017 / Cilt: 52 - Sayı: 4

Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients

Çocuk hematoloji-onkoloji hastalarının febril nötropeni ataklarının değerlendirilmesi

Pages
213–220
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

C-reactive protein levels in microbiologically documented infections were higher than in clinically documented infections, and fever of unknown origin (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Febrile neutropenia is an important cause of mortality and morbidity in hematology-oncology patients undergoing chemotherapy.
📊
Key Findings & Data:The objective of this study was to evaluate febrile neutropenic episodes in children with malignancy.Material and Methods: Sixty-eight children who received chemotherapy for malignancy between 2010 and 2015 were retrospectively reviewed.
💡
Conclusion & Impact:C-reactive protein levels in microbiologically documented infections were higher than in clinically documented infections, and fever of unknown origin (p
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Febrile neutropenia is an important cause of mortality and morbidity in hematology-oncology patients undergoing chemotherapy. The objective of this study was to evaluate febrile neutropenic episodes in children with malignancy.Material and Methods: Sixty-eight children who received chemotherapy for malignancy between 2010 and 2015 were retrospectively reviewed. The demographic characteristics, laboratory data, infection foci, and frequency of microorganisms grown in culture were examined. Also, the frequency of febrile neutropenic attacks was investigated according to the chemotherapy periods.Results: Of the total 200 episodes, 81 (40.5%) were clinically documented, and 73 (36.5%) were microbiologically documented infections. Fever of unknown origin was observed in 46 (23%) episodes. The most frequently clinically documented focus were mucositis (33.4%) and pneumonia (24.7%). Blood culture was positive in 55 (75.3%) episodes of microbiologically documented infections. The most commonly isolated microorganisms in blood culture were Gram-negative bacteria (47.2%). C-reactive protein levels in microbiologically documented infections were higher than in clinically documented infections, and fever of unknown origin (p

Özet

Amaç: Febril nötropeni, kemoterapi alan hematoloji-onkoloji hastalarında hastalık ve ölümün en önemli nedenidir. Bu çalışmanın amacı maliniteli çocuk hastaların febril nötropeni ataklarının değerlendirilmesidir.Gereç ve Yöntemler: Malinite nedeni ile 2010 ve 2015 yılları arasında kemoterapi verilen 68 çocuk hastanın dosya bilgileri geriye dönük olarak incelendi. Hastaların demografik özellikleri, laboratuvar ölçümleri, enfeksiyon odakları ve kültürde üreyen mikroorganizmaların sıklığı incelendi. Ayrıca kemoterapi dönemlerine göre febril nötropenik atak sıklığı araştırıldı.Bulgular: İki yüz febril nötropenik atağın 81'inde (%40,5) klinik olarak tanımlanmış enfeksiyon odağı 73'ünde (%36,5) mikrobiyolojik olarak tanımlanmış enfeksiyon odağı vardı. Atakların 46'sında (%23) herhangi bir enfeksiyon odağı bulunamadı. Klinik olarak en sık görülen enfeksiyon odağı mukozit (%33,4) ve pnömoni (%24,7) idi. Mikrobiyolojik olarak tanımlanmış enfeksiyon ataklarının 55'inde (%75,3) kan kültüründe mikroorganizma izole edildi. Kan kültüründe en sık izole edilen etken gram negatif mikroorganizmalardı (%47,2). Mikrobiyolojik olarak tanımlanmış enfeksiyonlarda C-reaktif protein düzeyi klinik olarak tanımlanmış enfeksiyonlardan ve nedeni bilinmeyen ateş ataklarından yüksekti (p

🔖

Cite This Article

BÖR, Ö., ÖZDEMİR, Z. C., KAR, Y. D. (2022). Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients. Türk Pediatri Arşivi, Cilt: 52 - Sayı: 4, 213–220. https://ajindex.com/articles/641118

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Crokaert F. Febrile neutropenia in children. Int J Antimicrob Agents 2000; 16: 173-6. [CrossRef ] 2. Basu SK, Fernandez ID, Fisher SG, Asselin B L, Lyman GH. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol 2005; 23: 7958-66. [CrossRef ] 3. Bakhshi S, Padmanjali KS, Arya LS. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol 2008; 25: 385-92. [CrossRef ] 4. Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Infect Dis 2007; 11: 513-17. [CrossRef ] 5. Blennow O, Ljungman P. The challenge of antibiotic resis¬tance in haematology patients. Br J Haematol 2016; 172: 497- 511. [CrossRef ] 6. Mikulska M, Viscoli C, Orasch C, et al. Aetiology and resistance in bacteremias among adult and pediatric haematology and cancer patients. J Infect 2014; 68: 321-31. [CrossRef ] 7. Ortega M, Marco F, Soriano A, et al. Epidemiology and outcome of bacteremia in neutropenic patients in a single institution from 1991-2012. Epidemiol Infect 2015; 143: 734-40. [CrossRef ] 8. Gudio C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013; 19: 474-9. [CrossRef ] 9. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52: 56- 93. [CrossRef ] 10. Kebudi R, Devecioğlu Ö, Gürler N. Pediatrik febril nötropeni kılavuzu. Flora 2004; 9: 73-105. 11. Paul M, Gafter-Gvili A, Leibovici L, et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Isr Med Assoc J 2007; 9: 424-9. 12. Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bökenkamp A. Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer 2011; 56: 868-70. [CrossRef ] 13. Clarke RT, Jenyon T, van Hamel Parsons V, King AJ. Neutropenic sepsis: management and complications. Clin Med 2013; 13: 185-7. [CrossRef ] 14. Aparicio J, Oltra A, Llorca C, et al. Randomized comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients. Eur J Cancer 1996; 32: 1739-43